Dr. Ramesh brings over 20 years of expertise in the pharmaceutical industry and his extensive experience across R&D, Compliance, Regulatory, Business development, Artificial intelligence.
Dr. Pennamareddy has held senior positions at renowned pharmaceutical companies such as Glenmark, Amneal, and Chemo (Insud Group). He has played a crucial role in regulatory submissions and securing approvals for both generic and innovative products for the US, EU and global market. His achievements include numerous First-to-File (FTF), First-to-Market (FTM), PFC, and CGT designated complex sterile and ophthalmic suspensions, as well as drug-device combination products.
Dr. Pennamareddy earned his Master’s degree in Microbiology from Nagarjuna University and his Ph.D. in Life Sciences from Bharathidasan University, Leadership in AI from Indian School of Business. He is also an active member of various pharmaceutical associations, contributing to the industry’s growth and innovation.
